Certified by Founder Lodge 
                                        
                                        Westlake Village BioPartners®
 
                                                 United States  -  Westlake Village, California (CA) 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $51,000,000
                                            5 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Our firm brings Silicon Valley access and experience to Los Angeles, an emerging biotech community that is fresh, unorthodox and exciting. 
We are playing our part catalyzing the biopharma
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Kate Therapeutics | 
                                                            June, 08 ,2023 | Series A | $51,000,000 | 
   Kyverna Therapeutics | 
                                                            August, 03 ,2023 | Series B | $60,000,000 | 
   Star Therapeutics | 
                                                            September, 05 ,2023 | Series C | $90,000,000 | 
   Latigo Biotherapeutics, Inc. | 
                                                            February, 15 ,2024 | Series A | $135,000,000 | 
   Arsenal Biosciences, Inc. | 
                                                            September, 05 ,2024 | Series C | Undisclosed Amount | 
                                                
  Kate Therapeutics
  Kyverna Therapeutics
  Star Therapeutics
  Latigo Biotherapeutics, Inc.
  Arsenal Biosciences, Inc.
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)